The American Society of Hematology (ASH) meeting is in full swing, and Day 2 brought some exciting news.…
Fulcrum Therapeutics recently announced promising results from a study on their experimental pill for sickle cell disease. The…
The event hosted by Scientific American at Morehouse School of Medicine in Atlanta, Georgia was a significant gathering…
The landscape of treatment for patients with sickle cell disease and beta-thalassemia is undergoing a significant transformation. Breakthroughs…
The Centers for Medicare and Medicaid Services recently announced a new program aimed at improving patient access to…
In a striking revelation, New York Attorney General Leticia James was made aware of a conspiracy to stifle…
A groundbreaking gene therapy treatment has successfully cured a 21-year-old man in New York of sickle cell anemia,…
Coercive Care: The Story of Pat Wells You're reading Part 6 of Coercive Care, a yearlong examination of…
SAN DIEGO — The recent withdrawal of Pfizer's sickle cell drug Oxybryta has sparked outrage among sickle cell…
The Republican party and President-elect Donald Trump have a long list of changes they want to make to…
You're reading Part 5 of Coercive Care You're reading Part 5 of Coercive Care, a yearlong examination of…
Sickle cell disease is a genetic illness that disproportionately affects Black Americans and is associated with an increased…
Sign in to your account